Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir Patents

Given below is the list of patents protecting Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir's patents.

Latest Legal Activities on Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir's Patents

Given below is the list recent legal activities going on the following patents of Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir.

Activity	Date	Patent Number
Critical Events This Week
Payment of Maintenance Fee, 12th Year, Large Entity	12 Oct, 2023	US8188104
Payment of Maintenance Fee, 8th Year, Large Entity	08 Feb, 2023	US9139536
Payment of Maintenance Fee, 8th Year, Large Entity	09 Nov, 2022	US9044480
Payment of Maintenance Fee, 8th Year, Large Entity	14 Sep, 2022	US9006387
Payment of Maintenance Fee, 4th Year, Large Entity	13 Jul, 2022	US10201541
Payment of Maintenance Fee, 4th Year, Large Entity	13 Jul, 2022	US10201584
Post Issue Communication - Certificate of Correction	10 May, 2022	US9744170
Email Notification Critical	04 May, 2022	US9744170
Electronic Review Critical	04 May, 2022	US9744170
Mail Certificate of Correction Memo	03 May, 2022	US9744170

Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir's Family Patents

Full family tree

Explore Our Curated Drug Screens